SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. (Q54559255)

31 May 2018

title

SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. (English)

1 reference

31 May 2018

0 references

1 reference

6

1 reference

31 May 2018

author name string

Paulo Caleb Junior Lima Santos

1

1 reference

31 May 2018

Ana Carolina Moron Gagliardi

2

1 reference

31 May 2018

Márcio Hiroshi Miname

3

1 reference

31 May 2018

Ana Paula Chacra

4

1 reference

31 May 2018

Raul Dias Santos

5

1 reference

31 May 2018

Alexandre Costa Pereira

7

1 reference

31 May 2018

publication date

18 September 2011

1 reference

31 May 2018

European Journal of Clinical Pharmacology

published in

1 reference

31 May 2018

volume

68

1 reference

31 May 2018

issue

3

1 reference

31 May 2018

page(s)

273-279

1 reference

31 May 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

The genetics of statin-induced myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

SLCO1B1 variants and statin-induced myopathy--a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

The safety of statins in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Statin safety: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

The SLCO1B1*5 genetic variant is associated with statin-induced side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Characterization of hepatobiliary transport systems of a novel alpha4beta1/alpha4beta7 dual antagonist, TR-14035.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Familial hypercholesterolemia: current treatment and advances in management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in Utah

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Ethnicity and arterial stiffness in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1125-1

An assessment of statin safety by muscle experts

21 January 2018

1 reference

12 December 2020

Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.

1 reference

12 December 2020

Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study

1 reference

12 December 2020

Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method

1 reference

12 December 2020

Statins, cardiovascular disease, and drug safety

1 reference

12 December 2020

Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients

1 reference

12 December 2020

10.1007/S00228-011-1125-1

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018